NKARTA INC (NKTX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NKTX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NKTX | President | ["Formerly served as Chief Executive Officer at Rezo Therapeutics","Chief Financial and Business Officer at the company","Chief Business Officer from September 2019 to October 2020","Senior Vice President, Corporate Development from May 2018 to September 2019","Held positions at Second Genome, Inc. between March 2012 and April 2018","Equity Research Fellow in Global Investment Research at Goldman Sachs Inc.","Postdoctoral research at the Scripps Research Institute","Staff Scientist at Kythera Biopharmaceuticals"] | ["Chair of the Board of Directors of California Life Sciences"] | 2026 |
Biography sourced from the proxy statement filing.
Nadir Mahmood, Ph.D. has served as our President since July 2024. Dr. Mahmood formerly served as the Chief Executive Officer at Rezo Therapeutics, a privately held biopharmaceutical company, from July 2023 to June 2024. Prior to joining Rezo, Dr. Mahmood served as our Chief Financial and Business Officer from October 2020 to June 2023, Chief Business Officer from September 2019 to October 2020 and Senior Vice President, Corporate Development from May 2018 to September 2019. Dr. Mahmood previously held positions of increasing responsibility at Second Genome, Inc., a privately held biopharmaceutical company, between March 2012 and April 2018. Prior to joining Second Genome, Dr. Mahmood was an Equity Research Fellow in Global Investment Research at Goldman Sachs Inc. from January 2011 to July 2011. Dr. Mahmood conducted postdoctoral research at the Scripps Research Institute in La Jolla, CA from August 2009 to January 2011. Dr. Mahmood began his career as Staff Scientist at Kythera Biopharmaceuticals, Inc., which was acquired by Allergan in 2015. Dr. Mahmood currently serves as Chair of the Board of Directors of California Life Sciences. Dr. Mahmood holds a B.S. in Biochemistry from the University of Texas at Austin and a Ph.D. in Cell Regulation from the University of Texas Southwestern Medical Center at Dallas.